Chongqing Primary Aldosteronism Study
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
We intends to conduct a series of original clinical research about PA, and establish a large cohort of PA and essential hypertension patients with long-term follow-up of cardiovascular events, renal end points etc. We will establish a large sample of blood, urine, adrenal tissue of the subjects, and the genomics,metabonomics, proteomics database, to explore the mechanism of the PA and target organ damage, risk factors, diagnostic methods and biomarkers.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• hypertensive patients who completed ARR screening and necessary further tests;
• Voluntary to sign the informed consent.
Locations
Other Locations
China
Qifu Li
RECRUITING
Chongqing
Contact Information
Primary
Qifu Li, phD
liqifu@yeah.net
+86 023-89011552
Backup
Shumin Yang, phD
443068494@qq.com
+86 023-89011552
Time Frame
Start Date: 2016-10-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 1500
Treatments
Primary aldosteronism
screened, confirmed and subtyped according to the guidelines.
Essential hypertension
screened for PA and excluded the diagnosis of PA as well as other secondary hypertesion
Related Therapeutic Areas
Sponsors
Leads: Chongqing Medical University